Syndecan-4 is the key proteoglycan involved in mediating sepsis-associated lung injury

por Zhu, Zhipeng, Ling, Xiaoyan, Zhou, Hongmei, Xie, Junran
Publicado 2023

Dexmedetomidine at a dose of 1 µM attenuates H9c2 cardiomyocyte injury under 3 h of hypoxia exposure and 3 h of reoxygenation through the inhibition of endoplasmic reticulum stress...

por Zhu, Zhipeng, Ling, Xiaoyan, Zhou, Hongmei, Zhang, Caijun
Publicado 2021

Dexmedetomidine Attenuates Cellular Injury and Apoptosis in H9c2 Cardiomyocytes by Regulating p-38MAPK and Endoplasmic Reticulum Stress

por Zhu, Zhipeng, Ling, Xiaoyan, Zhou, Hongmei, Zhang, Caijun, Yan, Weiwei
Publicado 2020

Does dexmedetomidine have an antiarrhythmic effect on cardiac patients? A meta-analysis of randomized controlled trials

por Ling, Xiaoyan, Zhou, Hongmei, Ni, Yunjian, Wu, Cheng, Zhang, Caijun, Zhu, Zhipeng
Publicado 2018

Can dexmedetomidine reduce atrial fibrillation after cardiac surgery? A systematic review and meta-analysis

por Zhu, Zhipeng, Zhou, Hongmei, Ni, Yunjian, Wu, Cheng, Zhang, Caijun, Ling, Xiaoyan
Publicado 2018

Transforming growth factor-β1-induced podocyte injury is associated with increased microRNA-155 expression, enhanced inflammatory responses and MAPK pathway activation

por Zheng, Xintong, Zhong, Qiuhong, Lin, Xu, Gu, Xianjun, Ling, Xiaoyan, Liang, Zhao, Qin, Qing, Du, Xiuri
Publicado 2021